Editorial: Managing COVID-19 in heart and lung transplantation: clinical challenges and emerging solutions - Takeaways - MDSpire

Editorial: Managing COVID-19 in heart and lung transplantation: clinical challenges and emerging solutions

  • By

  • Chengliang Yang

  • Wenjun Mao

  • Ömer Senbaklavaci

  • April 17, 2026

  • 0 min

Share

  • 1

    COVID-19 poses significant challenges in heart and lung transplantation, affecting infection risk and long-term outcomes.

  • 2

    Transplant recipients are vulnerable due to chronic immunosuppression, high comorbidity, and impaired immune responses to vaccination.

  • 3

    Research indicates that sirolimus may increase the risk of severe COVID-19, necessitating individualized immunosuppression strategies.

  • 4

    Long COVID affects approximately 5% of solid organ transplant recipients, with unclear implications for graft failure and mortality.

  • 5

    Therapeutic management of COVID-19 in immunocompromised patients presents challenges due to potential drug-drug interactions.

Original Source(s)

Editorial: Managing COVID-19 in heart and lung transplantation: clinical challenges and emerging solutions

  • by Chengliang Yang, Wenjun Mao, Ömer Senbaklavaci

  • April 17, 2026

Related Content

How future surgery will benefit from SARS-COV-2-related measures: a SPIGC survey conveying the perspective of Italian surgeons

Scientific requisites for academic advancements in Italy: time to change the rules

When to operate after SARS-CoV-2 infection? A review on the recent consensus recommendation of the DGC/BDC and the DGAI/BDA